Robert Van Gog

Title: Innovations by Robert Van Gog

Introduction

Robert Van Gog is an accomplished inventor based in Eindhoven, Netherlands. He has made significant contributions to the field of bioinformatics, particularly in the area of clinical risk assessment. With a total of 2 patents, his work focuses on developing methods that enhance the prognosis of negative clinical events.

Latest Patents

Van Gog's latest patents include a bioinformatics process for identifying at-risk subject populations. This method determines a risk score that indicates the likelihood of a subject experiencing a negative clinical event within a specified timeframe. The risk score is derived from the activities of two or more cellular signaling pathways, specifically the PI3K pathway and one or more of the Wnt, ER, and HH pathways. The invention also encompasses an apparatus with a digital processor designed to execute this method, along with a non-transitory storage medium that contains executable instructions. This innovation aims to provide advanced prognosis for various negative clinical events, such as disease progression, recurrence, metastasis, or even death.

Another notable patent is a superior bioinformatics process for identifying at-risk subject populations. This method also calculates a risk score based on a unique combination of cellular signaling pathways, including the TGF-β pathway and one or more of the PI3K, Wnt, ER, and HH pathways. Similar to his previous invention, this patent includes an apparatus with a digital processor and a computer program that facilitates the execution of the method. This bioinformatics invention allows for more accurate prognoses of specific negative clinical events in patients with tumors or cancer.

Career Highlights

Robert Van Gog is currently employed at Koninklijke Philips Corporation N.V., where he continues to innovate in the field of bioinformatics. His work has the potential to significantly impact patient care and clinical outcomes.

Collaborations

Some of his notable coworkers include Hendrik Jan Van Ooijen and Anne Godefrida Catharina Van Brussel. Their collaborative efforts contribute to the advancement of bioinformatics and clinical research.

Conclusion

Robert Van Gog's contributions to bioinformatics through his innovative patents demonstrate his commitment to improving clinical risk assessment. His work not only enhances the understanding of cellular signaling pathways but also aims to provide better prognostic tools for healthcare professionals.